Fairvalue-Calculator Fairvalue-Calculator
EN DE

HLB Genex, Inc (187420) Fair Value & Analysis

Basic Materials · KR · Market cap 66.3B KRW

Price2,080 KRW
Fair Value2,233 KRW
Upside+7.3%
Quality80/100
Evidence: Medium Range 1,675 KRW – 2,791 KRW

Fair value as of: Jun 24, 2026

Analysis

HLB Genex, Inc (187420) currently trades at 2,080 KRW, while our model-based Fair Value estimate is 2,233 KRW — implying the stock looks roughly 7.3% undervalued today. We read business quality at 80/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2. The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, oral mucositis, nonalcoholic steatohepatitis, diabetic macular edema, and dry eye indications. The company was formerly known as GenoFocus, Inc. HLB Genex, Inc. was founded in 2000 and is based in Daejeon, South Korea.

Open the full interactive analysis →

Similar stocks

Linde plc (LIN) -69% L'Air Liquide S.A (AIQUY) -59% Air Products and Chemicals, Inc (A1PD34) -86% Intercontinental Exchange, Inc (I1CE34) -80% Wanhua Chemical Group (600309) -8% Asian Paints Limited (ASIANPAINT) -75%

Frequently asked questions

Is HLB Genex, Inc (187420) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,233 KRW versus a price of 2,080 KRW — about +7% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 187420?
Our 21-model fair value for HLB Genex, Inc is 2,233 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 2,080 KRW.
What is the quality score of 187420?
HLB Genex, Inc has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.